Prostate Cancer Trial, Recruiting (NCT06547398)

Prostate Cancer Trial, Recruiting NCT06547398 Sponsor: Royal North Shore Hospital Condition: Prostate Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06547398 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Prostate Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are over 18 years of age
People who have been diagnosed with prostate cancer confirmed by a biopsy
People whose planned treatment is radiation therapy to the prostate only (no surgery or other treatment)
People who are reasonably active and able to care for themselves, with only limited physical restrictions (this is measured using a standard medical scale called ECOG, scores 0–2)
People who are able to understand the study information and are willing to sign a consent form

Who may not be able to join:

People who have a hip replacement (hip prosthesis) on either side
People where the distance from the prostate to the edge of the skin measures more than 24cm on a diagnostic scan (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Andrew Prof Kneebone, MBBS, Northern Sydney Local Health District

Phone: +61294631345

Australian sites

Northern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, New South Wales
+61294631300

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06547398

Sponsor: Royal North Shore Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Prostate Cancer

Trial contact: +61294631345

More information: https://clinicaltrials.gov/study/NCT06547398

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are over 18 years of age
People who have been diagnosed with prostate cancer confirmed by a biopsy
People whose planned treatment is radiation therapy to the prostate only (no surgery or other treatment)
People who are reasonably active and able to care for themselves, with only limited physical restrictions (this is measured using a standard medical scale called ECOG, scores 0–2)
People who are able to understand the study information and are willing to sign a consent form

Who may not be able to join:

People who have a hip replacement (hip prosthesis) on either side
People where the distance from the prostate to the edge of the skin measures more than 24cm on a diagnostic scan (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Royal North Shore Hospital

Registry

ClinicalTrials.gov

Start date

1 October 2025

Est. completion

31 October 2029

Where this trial is recruiting

🇦🇺 Australia

1 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Safety of Adaptive Radiation Therapy via Radiation Therapists-led* treatment delivery (CTV coverage); Safety of Adaptive Radiation Therapy via Radiation Therapists-led* treatment delivery (OAR DVH constraints); Feasibility of ART via RT-led* treatment delivery; Acute patient reported toxicity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov